scholarly article | Q13442814 |
P50 | author | Michael W Lipscomb | Q92262299 |
P2093 | author name string | Simon C Watkins | |
Walter J Storkus | |||
Jennifer L Taylor | |||
Amy K Wesa | |||
Cristina J Goldbach | |||
P2860 | cites work | Human T regulatory cell therapy: take a billion or so and call me in the morning | Q24656069 |
The emerging roles of forkhead box (Fox) proteins in cancer | Q28253741 | ||
The evolution of Fox genes and their role in development and disease | Q28751831 | ||
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells | Q30438648 | ||
Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination | Q33825567 | ||
miRNA regulation of cytokine genes | Q35086852 | ||
Heterogeneity of CD4(+) and CD8(+) T cells | Q35145793 | ||
CD8+ T suppressor cells are back to the game: are they players in autoimmunity? | Q35172060 | ||
Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells | Q35575723 | ||
Dendritic-cell control of pathogen-driven T-cell polarization | Q35597117 | ||
Transient regulatory T-cells: a state attained by all activated human T-cells. | Q35792962 | ||
Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens | Q35826361 | ||
Expanding role of T-cell costimulators in regulatory T-cell function: recent advances in accessory molecules expressed on both regulatory and nonregulatory T cells | Q35978485 | ||
Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity | Q36202057 | ||
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice | Q36399304 | ||
Foxp3 in control of the regulatory T cell lineage | Q36794299 | ||
Indoleamine 2,3-dioxygenase and tumor-induced tolerance | Q36809762 | ||
Tolerogenic dendritic cells and the quest for transplant tolerance | Q36879029 | ||
Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease | Q36906673 | ||
Transforming growth factor-beta and the immune response: implications for anticancer therapy | Q36944384 | ||
Specificity of T-cell alloreactivity | Q37002818 | ||
IL-10: the master regulator of immunity to infection | Q37143028 | ||
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease | Q37331540 | ||
Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. | Q38305613 | ||
Regulatory T cells in the past and for the future | Q40105422 | ||
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production | Q40165347 | ||
The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. | Q41998069 | ||
Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells | Q42538765 | ||
Resistance of activated human Th2 cells to NO-induced apoptosis is mediated by gamma-glutamyltranspeptidase | Q43562668 | ||
HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination | Q44460752 | ||
Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. | Q44539418 | ||
T cell apoptosis by kynurenines. | Q44943853 | ||
Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | Q44986020 | ||
Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. | Q51098492 | ||
Functional connectivity between immune cells mediated by tunneling nanotubules. | Q51353454 | ||
Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death | Q56169018 | ||
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression | Q59048389 | ||
Foxp3 Expression in Pancreatic Carcinoma Cells as a Novel Mechanism of Immune Evasion in Cancer | Q61773591 | ||
Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse | Q73153290 | ||
Polarized type-1 dendritic cells (DC1) producing high levels of IL-12 family members rescue patient TH1-type antimelanoma CD4+ T cell responses in vitro | Q79467943 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 480-493 | |
P577 | publication date | 2010-02-01 | |
P1433 | published in | European Journal of Immunology | Q5412727 |
P1476 | title | DC expressing transgene Foxp3 are regulatory APC. | |
P478 | volume | 40 |
Q83485975 | Allogeneic apoptotic thymocyte-stimulated dendritic cells expand functional regulatory T cells |
Q91989902 | Chronic Hepatitis C: Conspectus of immunological events in the course of fibrosis evolution |
Q35643823 | Effects of Foxp3 gene modified dendritic cells on mouse corneal allograft rejection |
Q38875380 | FoxP3 Expression in Macrophages, Cancer, and B Cells-Is It Real? |
Q34631825 | How tolerogenic dendritic cells induce regulatory T cells |
Q36821053 | Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity |
Q36924962 | Lineage-specific transcription factors in unexpected places. |
Q34149057 | Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity? |
Q85110225 | Phenotypic and functional characterization of a CD4(+) CD25(high) FOXP3(high) regulatory T-cell population in the dog |
Q59129300 | Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3+ T cells in the primary transurethral resection of bladder tumor specimens |
Q35114346 | STAT6 expression in multiple cell types mediates the cooperative development of allergic airway disease |
Q39009363 | Transgene IL-6 enhances DC-stimulated CTL responses by counteracting CD4+25+Foxp3+ regulatory T cell suppression via IL-6-induced Foxp3 downregulation |
Search more.